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Summary In a population-based case-control study of lung cancer in Shanghai involving interviews during
1984-86 with 1,405 cancer patients and 1,495 controls, a significant 50% elevation in the risk of lung cancer,
adjusted for cigarette smoking, was observed among persons who had a history of tuberculosis. Among those
diagnosed with tuberculosis within the past 20 years, the risk exceeded 2.5-fold. In males the lung cancers
tended to occur on the same side as the previous tuberculosis infection. For both sexes, the effect of recent
tuberculosis was most apparent for adenocarcinoma and peripheral tumours. No relationship was found
between lung cancer risk and the type of tuberculosis therapy, including use of isoniazid. The findings suggest
that tuberculosis may predispose to lung cancer, with the association most apparent among recent survivors
of the infection.
The possible relationship between pulmonary tuberculosis
(TB) and the subsequent development of lung cancer has
attracted attention for several decades. There have been
numerous clinical reports of concurrent lung cancer and TB,
and of cancers, especially adenocarcinoma and peripheral
tumours, arising from TB scars (Auerbach et al., 1979;
Bakris et al., 1983). Some epidemiologic investigations
(Hinds et al., 1982; Howe et al., 1979; Clemmesen & Jensen,
1979; Campbell & Guilfoyle, 1970; Steinitz, 1965; Campbell,
1961), but not all (Boice & Fraumeni, 1980; Stott et al.,
1976; Hammond et al., 1967), have suggested that TB
patients are at significantly increased risk of lung cancer,
although data on histologic types and smoking habits were
often unavailable. In this paper we use information from a
population-based case-control study of lung cancer in
Shanghai, where lung cancer rates are high and pulmonary
TB has been common, in an attempt to clarify the
relationship of TB to lung cancer.
Methods
The patients in this case-control study were men between the
ages 35 to 64 and women between the ages 35 to 69 who
resided in the ten urban areas of Shanghai and were newly
diagnosed with primary lung cancer (International
Classification of Diseases Code, Ninth Revision, 162) during
the period 16 February 1984 to 15 February 1985 (males) or
to 15 February 1986 (females). The cases were identified
through the Shanghai Cancer Registry and a specially
established lung cancer rapid-reporting system operated by
the Shanghai Cancer Institute. All hospitals in the Shanghai
urban area reported to this system. The diagnoses of lung
cancer were reviewed by a panel of four pulmonary disease
physicians, with all slides checked by two senior pathologists.
Controls were selected via a sex and age-stratified random
sample of the general population of the Shanghai urban
area. The proportion of the controls in each sex and 5-year
age group between the ages of 35 to 69 was chosen to be
similar to the proportion of lung cancer cases in that sex and
age group reported to the Shanghai Cancer Registry during
1980-81. A total of 1,495 controls were sought. To obtain a
control in a particular sex and age group, a neighbourhood
committee (an administrative area) was randomly selected
from among the nearly 1,300 in urban Shanghai. In
Shanghai each neighbourhood committee contains between
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3,500 and 5,000 individuals and is further subdivided into
about 10-15 household groups. A household group within
the neighbourhood committee was then randomly selected
and the names of all males or females within the 5-year age
group were collected. Among all the eligible persons in the
given age group, two potential controls were randomly
identified. If an interview could not be obtained from the
first control, then the second control was selected.
Interviews were sought with all living cases and controls.
The interviews were conducted in the subject's home, in the
hospital, or at the work site by trained interviewers. A
structured questionnaire was used, with nearly all questions
in closed form. Information was sought on prior lung
diseases, including TB, in addition to smoking history,
occupation, residence and other variables. If the respondent
reported that he or she had 'been diagnosed by a doctor as
having tuberculosis', he/she was asked a series of further
questions concerning the date of onset, method of treatment,
and the side of the lung affected by TB. Smokers were
defined as those who ever smoked cigarettes for a period of
6 months or longer. The smokers were then classified as
light, moderate, or heavy smokers, respectively, according to
whether they usually smoked fewer than 20 cigarettes per
day or smoked for less than 20 years (few who smoked less
than 20 years smoked 30 or more cigarettes per day);
smoked 20-29 cigarettes per day for 20 or more years; or
smoked 30 or more cigarettes per day for 20 or more years.
The odds ratio (OR) was the measure of association used
to evaluate the relationship between TB and lung cancer.
Potential confounding by age, smoking (using the above-
mentioned categories), and education was controlled by
calculating summary ORs using the Mantel-Haenszel
technique and stratified logistic regression analyses (Breslow
& Day, 1980).
Results
A total of 833 male and 765 female cases of primary lung
cancer were identified over the 12-month (male) or 24-month
(female) ascertainment period. There were 94 male and 93
female cases who died before they could be asked to
participate in the study. An additional 6 refused to
cooperate. Interviews thus were obtained for a total of 1,405
cases, 99% of those eligible and 88% of all incident cases in
Shanghai.
Among males 62% of the lung cancer diagnoses were
based on pathologic examination of tissue specimens, 30%
on cytology, and 7% on radiology. The corresponding
percentages for females were 43%, 38%, and 19%.
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Table I Percentage distribution of cases and controls
by age, education, and occupation
Male
Age
35-49
50-54
55-59
60-64
65+
Education
No formal school
Primary school
Middle school
College
Others
Occupation
Professional &
government
Clerical & sales
Blue collar
House wives
N
Fenmale
Cases Controls Cases Controls
8.2 9.9 11.5
16.1 15.0 16.1
35.3 29.1 23.5
40.4 46.1 28.6
_ - 20.4
15.4
41.5
32.6
7.8
2.7
11.2
39.1
39.6
7.5
2.6
39.7
28.9
18.9
4.0
8.5
9.9
12.4
20.4
25.7
31.6
42.6
26.8
17.4
3.1
10.1
17.6 22.6 13.7 11.4
14.8 14.0 6.8 8.7
67.6 63.4 70.2 69.7
- - 9.2 10.2
733 760 672 735
Table II Odds ratios for lung cancer associated with prior
tuberculosis infection
Adjustedl"
Crudle
Ca.ses Controls OR OR 95% CI
Prior diagnosis of TB
No 1105 1279 1.0 1.0 -
Yesb 266 213 1.4 1.5 (1.2-1.8)
Years since
diagnosis of TB
3-9 26 12 2.5 2.5 (1.2-5.2)
10-19 46 18 3.0 2.8 (1.6-5.0)
20-29 103 105 1.1 1.1 (0.8-1.5)
30+ 91 78 1.4 1.5 (1.0-2.1)
aAdjusted for smoking, age, education, and sex; bExcludes 10
cases and 3 controls with missing data on year of TB diagnosis and
24 cases diagnosed within 3 years of interview.
Table III Odds ratios for lung cancer by years since TB diagnosis
according to smoking status
SmoAkin?g categori1'
Years since
TB diagnosis Cases Controls OR 95% CI
Ascertainment of histology was obtained for 1,221 (87%) of
the cases.
Interviews were obtained for 1,495 controls. Only 8 (1%)
eligible controls refused to cooperate, but 60 had moved or
were temporarily living outside of Shanghai, 19 had died or
were too ill to be interviewed, 44 were out of the appropriate
age range, and 8 were not interviewed for other reasons. For
these 139 (9% of the total), interviews were obtained from
the second control. Table I shows that male cases and
controls were approximately the same age, but more cases
were less educated and held blue collar jobs. Among females
the percentage of interviewed cases age 65-69 was less than
anticipated, and cases tended to be slightly more educated.
Prior TB infection was reported by 26% of the cases and
20% of the controls among males, and by 12% and 8%,
respectively, among females, excluding the 24 cases and 0
controls with TB diagnosed within 3 years of interview and
10 cases and 3 controls with missing data on year of TB
diagnosis. The odds ratio for lung cancer associated with
prior tuberculosis was 1.5 (95% CI= 1.2-1.8), after
controlling for smoking, age, sex, education and occupation.
The OR for males (1.4; 95% CI 1.1-1.8) and females (1.6,
95% CI 1.1-2.3) were comparable. The risk of lung cancer
varied, however, according to the time when the TB was first
diagnosed (Table II). The ORs were highest among those
with TB diagnosed within 20 years of interview. This pattern
was not simply due to the high frequency of patients over
age 30 when TB was identified and treated, since the OR for
lung cancer among those diagnosed with TB within the past
20 years remained high when restricting the comparison to
those over age 30 at TB diagnosis. The effect of recency of
TB diagnosis also persisted regardless of the method of
diagnosis of lung cancer, with OR associated with TB
infection in the past 20 years exceeding 2.5 regardless of
whether the diagnosis of lung cancer was based on tissue
examination, cytology, or radiologic/clinical grounds.
Although the OR were adjusted for smoking, there was
little confounding by smoking of the TB-lung cancer
association. Indeed, among controls, the smoking histories of
men with and without TB were comparable; 72% of those
with TB had smoked compared to 74% of those without TB,
and the percentages of heavy smokers were 7% and 6%,
respectively. Among female controls 180% had smoked
whether or not they had TB. We also examined the
consistency of the TB-cancer association across smoking
categories. As shown in Table III, the ORs for lung cancer
Non-smoker
Light smoker
Moderate smoker
Heavy smoker
Total
No TB
20 +
<20
No TB
20+
<20
No TB
20 +
<20
No TB
20 +
<20
No TB
20 +
<20
415
43
18
257
45
14
310
85
31
113
21
9
1105
194
72
714
83
9
331
57
15
197
32
6
37
11
0
1279
183
30
1.oa
1.0
3.5
1.0
1.2
1.5
1.0
1.9
4.2
1.0
0.7
S-
I.O 1 .00
1.2
2.7
(0.7-1.5)
(1.5-8.0)
(0.8-1.8)
(0.7-3.1)
(1.2-3.1)
(1.7-20.3)
(0.3-1.7)
(1.0-1.6)
(1.7-4.3)
aAdjusted for age, education and sex; 'Adjusted for smoking, age,
education and sex.
were elevated among those with a TB diagnosis in every
smoking category, including lifetime non-smokers. Further-
more, the ORs associated with TB did not vary greatly
across the smoking categories, with the greatest risk in each
category linked to recent (within 20 year) TB infections.
TB-related risks were also examined for specific cell types
of lung cancer and for peripheral vs. central lung cancer. As
shown in Table IV, the risks associated with recent TB were
increased both for adenocarcinoma and squamous/oat cell
carcinoma. Significantly elevated risks were also found for
both peripheral and central lung cancers. However, the risk
for peripheral lung cancer was greater, with nearly two-
thirds of the tumours being peripheral in patients with a
recent TB infection. Furthermore, the laterality of TB and
lung cancer was significantly (P<0.01) correlated (Table V).
When TB affected the left (right) lung, the patients more
often tended to have cancer on the left (right) side. The
closer associations of recent TB to adenocarcinoma and to
peripheral lung cancers was evident for both men and
women, but the laterality effect was limited to males.
The risks associated with various drug treatments for
tuberculosis are presented in Table VI. Most TB patients
(82%) were treated with isoniazid (INH), but no increased
risk was found for persons treated with INH alone or in
combination with other medications. Few of the cases or
controls with TB reported receiving artificial pneumothorax
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Table IV Odds ratios for lung cancer by histology, location, and years since TB diagnosis
Years since TB diagnosis
No TB 20 + Years <20 Years
N OR N OR 950'/oCI N OR 95%CI
Histologic type
Adenocarcinoma 448 1.0 61 1.1 (0.8-1.5) 30 3.2 (1.9-5.5)
Squamous/oat cell
carcinoma 406 1.0 94 1.4 (1.0-1.9) 30 2.6 (1.5-4.6)
Tumor location
Peripheral 493 1.0 85 1.2 (0.9-1.7) 43 3.8 (2.3-6.2)
Central 390 1.0 77 1.3 (1.0-1.9) 22 2.2 (1.2-4.1)
OR adjusted for smoking, age, education and sex.
Table V Sides of lung affected by TB and cancer
TB lo/atio/na
Leti sit/c Rig/t sitle Both sidles No TB
Lung cancer No. % No. % No. % No. %
Left side 39 52.0 35 31.5 14 35.0 370 38.3
Right side 29 38.7 65 58.6 23 57.5 477 49.4
Both sides 7 9.3 11 9.9 3 7.5 119 12.3
Total 75 100.0 111 100.0 40 100.0 966 100.0
"Excludes 40 cases with missing data on location of TB or lung
cancer.
Table VI Odds ratios for lung cancer associated with
drugs used by tuberculosis patients
Drulg Cases Contrt/ols OR' 95%CI
INH
Never 51 34 1.ob
Ever 215 179 0.7 (0.4-1.2)
Streptomycin
Never 113 94 I.Ob
Ever 153 119 1.0 (0.6-1.4)
aAdjusted for smoking, age, education, sex, and years
since TB diagnosis; bReferent category.
Discussion
This population-based study, in an area of the world where
lung cancer rates are comparatively high and where one-fifth
of the male population aged 40-64 has reported tuberculosis,
suggests that pulmonary TB is a risk factor for lung cancer.
The TB-lung cancer relation persisted after controlling for
smoking, with the risk of lung cancer in excess of 2.5-fold
among individuals with a TB infection within the past two
decades.
It seems unlikely that the association is simply due to the
misdiagnosis of TB in persons with early-stage lung cancer,
since the analysis included only TB patients diagnosed with
TB 3 or more years before the lung cancer was detected.
Few individuals with TB diagnosed in the 1970s or earlier
could have actually had a lung tumour clinically silent until
the mid 1980s, since the 5-year survival rate for lung cancer
is only about 7 percent in Shanghai (Shanghai Cancer
Institute, 1982). Conversely, the diagnosis of lung cancer in
1984-86 among some cases may have been incorrect,
especially among persons with chronic lung diseases such as
TB. We have some concern about the accuracy of the cancer
diagnosis, since confirmation was based on a histologic
examination of tumour tissue only for 62% of the male and
43% of the female patients. The association between lung
cancer and prior TB was still seen, however, when the
analysis was restricted to cases with pathologic confirmation.
Furthermore, most of those without pathology reviews of
tumour tissue had sputum cytology examinations, so that
only a small fraction of the cases were diagnosed only on
clinical and radiologic grounds.
It is possible that patients with clinically diagnosed TB,
particularly in recent years, were under intense medical
surveillance and thus more likely to have a lung cancer
diagnosed. This type of bias could be serious if lung cancer
often went undetected in the general population. Such is
probably not the case, however, since lung cancer rates in
Shanghai are high, not low, by world standards (Waterhouse
et al., 1982). In addition, we stratified the cases and controls
according to number of chest X-rays during their lifetimes,
one measure of medical surveillance relevant to the detection
of lung cancer, and found the lung cancer-TB relation held
regardless of X-ray frequency. Furthermore, the ascertain-
ment of lung cancer in this case-control study was thought
to be quite complete. All hospitals in Shanghai were checked
for lung cancer admissions, not just anti-TB or chest
hospitals where former TB patients would have been treated.
In addition, the high response rates (99% of all living
patients were interviewed) yielded a study sample nearly
equivalent to the total population of all diagnosed incident
lung cancer cases in Shanghai.
Another methodologic concern was the self-reporting of
tuberculosis by the respondents themselves, and the
possibility that cases would be more likely than the controls
to recall and report TB. It seems unlikely that this type of
bias is large, however, for the following reasons. Firstly,
Shanghai has had an active, anti-TB program, conducting
periodic mass X-ray screenings and offering standardized
methods of treatment. The diagnosis of TB generally
required the identification of acid-fast bacilli from bronchial
secretions together with evidence from chest radiographs and
physical signs. The TB patients were often isolated and given
combined drug therapy, usually INH, streptomycin and
para-aminosalicylic acid for 3 or more months. Thus, since
TB was a relatively major life event, it is likely to be easily
remembered. Secondly, we sought past medical records on 43
lung cancer patients who reported TB infections within the
past 15 years. For 21, records were found in TB registers
confirming the diagnosis. Among the remainder, visits to
families yielded confirmation for an additional 17, but not
for 2 cases, while the TB status of 3 was unknown. Hence
some confirmation was provided for 38 of the 43 patients. In
addition, this independent review found a nearly 90%
verification of the side of the lung affected with TB.
It is also possible that the lung cancer-TB association in
our study may be influenced by confounding risk factors for
lung cancer. In the analysis, however, we did adjust for the504 W. ZHENG et al.
effects of smoking, the dominant cause of lung cancer
among men and a significant contributor among women in
Shanghai. The association with TB was observed among
non-smokers and several categories of smokers. Social class,
as measured by education and occupation, was also taken
into account. Although poor nutritional status may be a risk
factor for lung cancer (Colditz et al., 1987), in our study the
relationship of nutrient intake to lung cancer risk was
inconsistent.
The increased risks of lung cancer associated with previous
TB were observed regardless of cell type and location.
However, the risks associated with a recent history of TB
(within 20 years of lung cancer diagnosis) were higher for
adenocarcinoma than squamous/oat cell cancers, with most
of the tumours arising in peripheral locations. These findings
are consistent with pathologic and clinical observations
linking TB lesions with lung cancer (Auerbach et al., 1979;
Bakris et al., 1983). Furthermore, among men with both TB
and lung cancer, there was a strong anatomic correlation
with both lesions tending to occur on the same side of the
lung. This correlation was not evident for females, but the
numbers of cases were smaller and information about the
localization of the tumour and TB was more often missing.
If the TB-lung cancer association is causal, the greater
risk of recent infection raises the possibility that TB may act
as a promoting or late-stage event in the carcinogenic
process. The precise mechanisms are unclear, but perhaps the
chronic TB inflammatory process potentiates the effects of
other carcinogenic exposures, traps the carcinogens in scar
tissue, evolves directly into a precacerous lesion, or enhances
abnormal cellular proliferation and growth. On the other
hand, it is also possible that the stronger link to recent TB
may simply be related to competing risk and dose-response
considerations. Severe TB infection in the pre-chemotherapy
era was often fatal, so patients diagnosed in the 1950s and
earlier would be less likely to survive to develop lung cancer.
Those with TB diagnosed more than 20 years ago and still
alive in the mid 1980s may have had, on average, less severe
infections than those with recent diagnoses. We have used 20
years as the dividing line between recent and past TB
infections not because of a priori hypotheses but rather
because of the sharp rise in the OR for lung cancer among
those with TB diagnosed within 10-19 or 3-9 compared to
20+ years of cancer diagnosis. Thus, inferences regarding
the aetiologic significance of differences in risk above and
below this data-derived 20-year cutoff must be interpreted
cautiously.
Despite the limited number of epidemiologic studies
evaluating the relationship between lung cancer and TB,
most have suggested a moderate increase in the risk of lung
cancer among TB patients. The largest was a cohort study of
64,000 TB patients in Canada to evaluate the late effects of
INH (Howe et al., 1979). A 1.5-fold excess risk of lung
cancer was found in patients with TB as compared to the
general population. Cohort studies in Australia (Campbell &
Guilfoyle, 1970; Campbell, 1961), Denmark (Clemmesen &
Jensen, 1979) and Israel (Steinitz, 1973) revealed 2-fold or
greater lung cancer risks among TB patients, with the
Australian study suggesting that the excess risk was not
confounded by smoking. On the other hand, little evidence
of an increased risk of lung cancer was detected in American
(Boice & Fraumeni, 1980; Hammond et al., 1967) or British
(Stott et al., 1976) surveys of TB patients, although the
numbers of expected cases were not large. A case-control
study in Hawaii revealed an 8-fold excess risk of lung cancer
in nonsmoking women with a history of TB, but only 4 cases
were affected (Hinds et al., 1982). None of these
investigations reported on the temporal association between
TB and lung cancer, so that further studies are needed to
evaluate our finding of enhanced cancer risk associated with
recent infections. As in previous studies, we found no
evidence that use of INH increases the risk of lung cancer,
although the drug produces lung tumours in mice
(International Agency for Research on Cancer, 1974). Since
few patients had repeated chest fluoroscopies associated with
artificial pneumothorax, the excess risk of lung cancer could
not be attributed to this source of radiation exposure.
In summary, the data from this large population-based
case-control study with exceptionally high response rates and
nearly complete coverage of the Shanghai population suggest
that TB is a risk factor for lung cancer, especially for TB
diagnosed within the past 20 years. If the link between lung
cancer and prior TB is a causal one, we estimate from
calculations of attributable risk that TB would account for
less than 10% of the lung cancers today in Shanghai. Thus,
despite the predilection of TB patients to develop lung
adenocarcinoma, it seems that the high prevalence of the
infection explains only a small part of the exceptionally high
rates of adenocarcinoma among nonsmoking Chinese women
(Koo et al., 1985). Further research is needed to clarify the
role of TB in lung cancer risk and the mechanisms by which
the disease may enhance carcinogenesis.
Supported in part by NCI Contract NOI-CP2-1012. We thank Dr
B.J. Stone, Ms Li Koo, and Ms Ruth Parsons for computer support,
and Dr Brian Henderson for helpful suggestions.
References
AUERBACH, O., GARFINKEL, L. & PARKS, V.R. (1979). Scar cancer
of the lung, increase over a 21 year period. Cancer, 43, 636.
BAKRIS, G.L., MULOPULOS, G.P., KORCHIK, R., EZDINLI, E., RO, J.
& YOON, B. (1983). Cancer, 52, 493.
BOICE, J.D. & FRAUMENI, J.F. JR. (1980). Late effects following
isoniazid therapy. Am. J. Public Health, 70, 987.
BRESLOW, N. & DAY, N.E. (1980). Th7e analysis of ccase-control
studies. IARC Scientific Publ. No. 32, Lyon.
CAMPBELL, A.H. (1961). The association of lung cancer and
tuberculosis. Aust. J. Med., 10, 126.
CAMPBELL, A.H. & GUILFOYLE, P. (1970). Pulmonary tuberculosis,
isoniazid and cancer. Br. J. Dis. Chest, 64, 141.
CLEMMESEN, J. & JENSEN, S.H. (1979). Is isonicotine acid hydrazide
(INH) carcinogenic to man? Ecotoxicol. Environ. Safety, 3, 439.
COLDITZ, G.A., STAMPFER, M.J. & WILLET, W.C. (1987). Diet and
lung cancer: A review of the epidemiologic evidence in humans.
Arch. Intern. Med., 147, 157.
HAMMOND, E.C., SELIKOFF, I.J. & ROBITZEK, E. (1967). Isoniazid
therapy in relation to later occurrence of cancer in adults and in
infants. Br. Med. J., 2, 792.
HINDS, M.W., COHEN, H.I. & KOLONEL, L.N. (1982). Tuberculosis
and lung cancer risk in nonsmoking women. Am. Rev. Respir.
Dis., 125, 776.
HOWE, G.R., LINDSAY, J., COPPOCK, E. & MILLER, A.B. (1979).
Isoniazid exposure in relation to cancer incidence and mortality
in a cohort of tuberculosis patients. lnt. J. Epidemiol., 8, 305.
KOO, L.C., HO, J.H. & LEE, N. (1985). An analysis of some risk
factors for lung cancer in Hong Kong. Int. J. Cancer, 35, 149.
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (1974).
Evaluation of the carcinogenic risk of chemicals to man, Vol. 4,
IARC: Lyon.
SHANGHAI CANCER INSTITUTE (1982). Analysis of cancer
incidence, survival and mortality rates in Shanghai urban area,
1972-1979. Shanghai Tumor, 2, 1.
STEINITZ, R. (1965). Pulmonary tuberculosis and carcinoma of the
lung. Am. Rev. Respir. Dis., (Suppl) 92, 758.
STOTT, H., PETO, J., STEPHENS, R. & 5 others (1976). An assessment
of the carcinogenicity of isoniazid in patients with pulmonary
tuberculosis. Tubercle, 57, 1.
WATERHOUSE, J., MUIR, C., SHANMUGARATNAM, K. & POWELL,
D. (eds) (1982). Cancer Incidence in Five Continents, Vol. IV,
IARC: Lyon.